Expert Review of Respiratory Medicine

Papers
(The H4-Index of Expert Review of Respiratory Medicine is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Redox signaling and antioxidant therapies in acute respiratory distress syndrome: a systematic review and meta-analysis104
A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination61
Relationship between patient functionality impairment and caregiver burden: is there a cut off point for the severe COPD patient?45
Evaluation of exacerbation severity in patients with COPD exacerbations according to the GOLD 2023 report32
Drug-induced interstitial lung disease: a narrative review of a clinical conundrum29
The effects of physical activity tele-counseling intervention on physical activity, functional performance, and quality of life in post-COVID-19 conditions: a randomized controlled trial28
Multidisciplinary bronchopulmonary dysplasia care26
Do all patients with cancer thrombosis have the same risk of bleeding and recurrence? Particularities of lung cancer26
How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?26
Moderate sedation with dexmedetomidine–remifentanil is safer than deep sedation with propofol–remifentanil for endobronchial ultrasound while providing comparable quality: a randomized double-blind tr26
What is personalized lung poromechanical modeling and how can it improve the understanding and management of fibrotic interstitial lung diseases?25
Diagnostic accuracy of interleukin-2 receptor in sarcoidosis: a systematic review and meta-analysis23
Assessing accuracy of testing and diagnosis in cystic fibrosis20
What is the future of inhaled antibiotics for bronchiectasis?20
The bleeding risk and safety of repeated bronchoscopies with tissue sampling in patients with pulmonary lesions20
Vaccination and modern management of chronic obstructive pulmonary disease – a narrative review20
Developments in smoking cessation interventions for patients with chronic obstructive pulmonary disease in the past 5 years: a scoping review19
Management of progressive pulmonary fibrosis associated with connective tissue disease18
The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis18
0.18490886688232